Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function.
about
Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders.Neurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodentsThe human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and functionAntidepressants as analgesics: an overview of central and peripheral mechanisms of action.Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice.Fear conditioning in frontotemporal lobar degeneration and Alzheimer's diseaseAirway-related vagal preganglionic neurons express multiple nicotinic acetylcholine receptor subunits.Effects of bupropion on simulated demand for cigarettes and the subjective effects of smokingDifferential effects of TRPV1 receptor ligands against nicotine-induced depression-like behaviors.Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior.Chemistry and pharmacological characterization of novel nitrogen analogues of AMOP-H-OH (Sazetidine-A, 6-[5-(azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol) as α4β2-nicotinic acetylcholine receptor-selective partial agonists.BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP.Recent developments in novel antidepressants targeting α4β2-nicotinic acetylcholine receptors.Translational Research on Nicotine Dependence.Nicotinic acetylcholine receptors as targets for antidepressants.Nicotine and nicotinic receptor antagonists potentiate the antidepressant-like effects of imipramine and citalopram.Inhibition of human alpha 7 nicotinic acetylcholine receptors by open channel blockers of N-methyl-D-aspartate receptors.The Selective Serotonin Reuptake Inhibitor Paroxetine, but not Fluvoxamine, Decreases Methamphetamine Conditioned Place Preference in Mice.Naturally-expressed nicotinic acetylcholine receptor subtypes.Cytisine, a Partial Agonist of α4β2 Nicotinic Acetylcholine Receptors, Reduced Unpredictable Chronic Mild Stress-Induced Depression-Like BehaviorsPotential therapeutic uses of mecamylamine and its stereoisomers.Physiological endpoints for potential SSRI interactions in fish.Weight and metabolic effects of dietary weight loss and exercise interventions in postmenopausal antidepressant medication users and non-users: a randomized controlled trial.Biological basis for the co-morbidity between smoking and mood disorders.Sigma-1 receptor ligands inhibit catecholamine secretion from adrenal chromaffin cells due to block of nicotinic acetylcholine receptors.The role of central mechanisms in the anti-inflammatory effect of amitriptyline on carrageenan-induced paw edema in ratsMolecular modelling of the interactions of carbamazepine and a nicotinic receptor involved in the autosomal dominant nocturnal frontal lobe epilepsyFluoxetine prevents acetylcholine-induced excitotoxicity blocking human endplate acetylcholine receptor.Antagonism of nicotinic acetylcholine receptors by inhibitors of monoamine uptake.Imaging brain phospholipase A2-mediated signal transduction in response to acute fluoxetine administration in unanesthetized rats.The effect of nicotine patch therapy on depression in nonsmokers: a preliminary study.Combined actions of zinc and fluoxetine on nicotinic acetylcholine receptors.Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests.Promoter IV-BDNF deficiency disturbs cholinergic gene expression of CHRNA5, CHRM2, and CHRM5: effects of drug and environmental treatments.Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamine.Fluoxetine effects on sheepshead minnow (Cyprinodon variegatus) locomotor activity.Translating the smoking cessation properties of the antidepressant nortriptyline using reinforcing, discriminative and aversive stimulus effects of nicotine in rats.
P2860
Q24532028-0404D69B-A63F-427A-AFF7-BDFAC44CC100Q24656267-C7DE1871-7ED2-4462-8EBA-965EAB3A3B03Q26821785-2A653479-843B-4412-A39B-9B1C35ECF98FQ28352180-8873D7E3-9F8C-441A-A9E4-987C2AF3AF69Q30487079-8E5C6B49-C02E-4074-BE49-E599093166FAQ30493304-C0C7C5EE-94F1-4377-AD23-707337DB74F0Q33240001-E68CA90F-887E-42DB-96EC-8DE6D554A670Q33759622-B2FFC8D5-A052-4B7E-9504-3D73C5CBDFE9Q33964434-DB8ED448-83B8-4029-9B18-52C50871E252Q34035211-D8010C13-63E6-4497-B52B-BB817432C1BEQ34215376-99BBBE63-9AD4-43B7-9B64-1B0965E50E7EQ34277168-C9553FB7-4C67-4514-9ACC-219C9091DD3CQ34394190-2532C15C-D90B-4DA1-A160-21DED0C11655Q34513939-0440A92F-175E-4120-AE53-46301BFE7E8FQ34761238-2DC5FA65-8373-411A-A0A9-B5FBE64411C6Q35045542-EEE1EAE6-9323-44F7-ACDB-F36C4AE8EAA3Q35045940-98EF0773-DD05-4160-B046-553F479099A9Q35107891-7CA5AA1A-5011-4DFB-931B-382C4A358143Q35185264-10DFCD54-A941-4B08-ADAD-3E9F2A13B887Q36879193-39374292-DC5B-4CF3-AF78-7F851F1FE9ACQ36949979-B69C709C-20D8-4B83-BFBA-14D24CA8EAD6Q37103805-32CA9397-E337-44F5-8A42-02AD1459978AQ37238741-3CC287EF-B3C6-4899-94D4-E21C6662D3B0Q37253537-BDDD5036-A2F0-4C79-A37F-F3252C1C271BQ38620929-C64537C9-CE00-4DC1-BE19-AA2B4C00C2ABQ41113546-494713C8-5F57-4263-B526-A4CAB75FCFCCQ41763594-3C9A4977-C5FD-4DE9-A52A-592E067C2359Q43456577-637C8301-F99D-4174-84E0-4B7DE652DCE3Q43722405-F8E399C9-864A-43D4-B221-4EF482EBDD8FQ44464149-9A4506D3-09E4-4306-8C35-84269E4CEC5AQ44728065-28142F2D-01B4-4825-BC73-CDC0719F89D9Q45049140-A2433B07-B073-4D55-85DF-497969952A09Q46516278-7D28C010-29AA-47D1-ADBF-BD17BCB41F62Q47135096-8DCBF18F-C326-41A9-BAE6-4D55724A1E8DQ48454295-A027A671-6E00-4325-88AC-FA26EE1DD179Q51581755-23B25B48-02CA-4B0F-8BAD-D871B215E859Q51860362-0BA24A43-C300-4138-B766-1CBFC3BB4409
P2860
Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function.
@en
type
label
Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function.
@en
prefLabel
Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function.
@en
P2860
P1476
Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function.
@en
P2093
P2860
P304
P356
10.1046/J.1471-4159.1999.0721117.X
P407
P577
1999-03-01T00:00:00Z